Pharmaceuticals (Therapeutic Medications)
Allergy - Immunotherapy
- Code of Federal Regulations
- First-Class Airman Medical Certificate: 67.105(b)(c)
- Second-Class Airman Medical Certificate: 67.205(b)(c)
- Third-Class Airman Medical Certificate: 67.305(b)(c)
The applicant should report frequency and duration of symptoms, any incapacitation by the condition, treatment, and side effects. The Examiner should inquire whether the applicant has ever experienced any barotitis (ear block), barosinusitis, alternobaric vertigo, or any other symptoms that could interfere with aviation safety.
- See Item 26, Nose, Aerospace Medical Disposition table
- Also see Aerospace Medical Disposition table and Item 35, Lungs and Chest
See Disease Protocols - Allergies, Severe .
- For conditions controlled by desensitization, AME must warn the airman to not operate aircraft until four hours after each injection.
- Sublingual immunotherapy (SLIT) used for allergic rhinitis is not acceptable.